Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion type Assertion NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_head.
- NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion description "[Eight genes are mapped for the AR-LGMDs; they are: LGMD2A (CAPN3) at 15q, LGMD2B (dysferlin) at 2p, LGMD2C (gamma-SG) at 13q, LGMD2D (alpha-SG) at 17q, LGMD2E (beta-SG) at 4q, LGMD2F (6-SG) at 5q, LGMD2G at 17q, and more recently LGMD2H at 9q.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_provenance.
- NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion evidence source_evidence_literature NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_provenance.
- NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion SIO_000772 10069710 NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_provenance.
- NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion wasDerivedFrom befree-20150227 NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_provenance.
- NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_assertion wasGeneratedBy ECO_0000203 NP692035.RA40a_VcEMcMGomjA8nw4wFCk8CsmMtgUWz2cuMngigWc130_provenance.